A reversed-phase column liquid chromatographic method was developed for the assay of amoxicillin and its preparations. The linear calibration range was 0.2 to 2.0 mg/ml (r = 0.9998), and recoveries were generally greater than 99%o. The high-performance liquid chromatographic assay results were compared with those obtained from a microbiological assay of bulk drug substance and capsule, injection, and granule formulations containing amoxicillin and degraded amoxicillin. At the 99%o confidence level, no significant intermethod differences were noted for the paired results. Commercial formulations were also analyzed, and the results obtained by the proposed method closely agreed with those found by the microbiological method. The results indicated that the proposed method is a suitable substitute for the microbiological method for assays and stability studies of amoxicillin preparations.
The present official assay method of the British Pharmacopoeia (8) for the analysis of potency of amoxicillin bulk drug is a mercury-nitrate titration. The U. S. Code ofFederal Regulations (14) , the United States Pharmacopeia (13) , and the Minimum Requirements forAntibiotic Products ofJapan (9) described three official methods for potency assay of amoxicillin preparations: a microbiological method, an iodometric assay, and an optical method. The regulations state that the results obtained from the microbiological method shall be conclusive.
However, there has recently been a move to replace expensive microbiological assays by chemical assays, e.g., high-performance liquid chromatography (HPLC). Several HPLC methods for the determination of amoxicillin in biological fluids have been reported (1, 2, 5-7, 11, 12, 15) . Fewer methods have been reported for degraded compounds or impure amoxicillin (3, 4) and for the determination of amoxicillin in pharmaceutical samples (10) .
In order to establish whether an HPLC method would be acceptable, it is important to determine whether it is robust enough for assaying samples kept under extreme conditions. Degradation in the sample should be equally reflected by microbiological and HPLC assays. This paper describes a comparison of a proposed HPLC method with a microbiological assay for the determination of amoxicillin in commercial formulations. Further, amoxicillin was kept at elevated temperatures as part of an accelerated degradation experiment and assayed by microbiological and HPLC methods.
MATERIALS AND METHODS
Instruments. A model 576 liquid chromatographic pump (Gasukuro Kogyo, Inc., Tokyo, Japan), a Gasukuro Kogyo model 502U spectrodetector, and a Gasukuro Kogyo model 12 chromatocorder were employed during the study. The mobile phase was pumped through a reversed-phase column (,uBondapak C18; inside diameter, 30 cm by 3.9 mm; particle size, 10 ,um; Waters P/N 27324) with an isocratic flow rate of * Corresponding author. Mobile phase. The mobile phase was methanol-1.25% acetic acid (20:80, vol/vol). The mobile phase was filtered (0.45-,um-pore-size Millipore filter) and degassed with an ultrasonic bath prior to use.
Amoxicilloate preparation. Amoxicilloate was prepared as described by De Pourcq et al. (3) . Amoxicillin trihydrate (100.0 mg) was dissolved in 20.0 ml of 0.1 N potassium hydroxide. After standing overnight, the solution was neutralized to pH 7.0 with 0.2 M potassiumn dihydrogen phosphate and diluted to 50.0 ml with water.
Internal-standard solution. Internal-standard acetaminophen (40.0 mg) was dissolved in 10.0 ml of methanol and diluted to 1.0 liter with water to form the internal-standard solution.
Amoxicillin standard solution. 10 .0 and 2.5 ,ug/ml with 1% phosphate buffer solution (pH 6.0) on the day of analysis. Five petri dishes with a 9.0-cm inside diameter were used for each sample. After incubation for 16 to 18 h, the inhibition zone diameter was measured by a zone analyzer (ZA-F; Toyo, Tokyo, Japan). 
RESULTS AND DISCUSSION
The linearity of the peak-area ratio (amoxicillin versus internal standard) was verified by injection of nine solutions containing amoxicillin in a concentration range of 0.2 to 2.0 mg/ml. A straight line with a correlation coefficient of 0.9998 (y = 0.0151 + 1.3457x) was obtained, as shown in Fig. 1 . Reproducibilities for both the within-day assay and the between-day assay were evaluated. The coefficients of variation, on the basis of peak-area ratios for six replicate injections in the within-day assay, were between 0.05 and 0.16% at the amount of 20 ,ug. The coefficient of variation in the between-day assay (n = 5) was 0.24% at the same amount.
The results of standard addition recovery studies of amoxicillin from sample composites of commercial preparations are shown in Table 1 . The average recovery was greater than 99%. These data indicate that the proposed HPLC method is relatively unaffected by the sample matrix.
Typical chromatograms of the amoxicillin commercial dosage forms are shown in Fig. 2 . The retention time was about 4.8 min for the internal standard and 3.8 min for amoxicillin. Excipients from commercial formulations did not interfere. Furthermore, the HPLC method can detect compounds related to amoxicillin, i.e., 6-aminopenicillanic acid and amoxicilloates, which were eluted prior to amoxicillin (Fig. 3) .
When samples of capsule, injection, and granule formulations were heat degraded, the resulting mixtures yielded chromatograms containing additional peaks, none of which interfered with the interpretation and measurement of the chromatographic peaks for amoxicillin and acetaminophen, as shown in Fig. 2 . Although only a little peak eluting just prior to amoxicillin was shown in Fig. 2 , several additional peaks were found when the detection sensitivity was increased. To examine the purity of the amoxicillin peak in the degraded sample (stored at 150°C for 7 min), a UV photo diode array detector was used. The evaluation of chromatographic peak homogeneity was performed with absorbance ratios and a three-dimensional spectrochromatogram. The results presented good confirmation of the amoxicillin peak identity (data not shown). In addition, a decrease in peak height (and/or peak area) with increase in temperature and time can be observed.
A number of samples of bulk drug substance and commercial preparations of eight brands were analyzed for amoxicillin content by HPLC. These samples were also assayed by the microbiological method. The results are shown in Table  2 . A t test was applied to the data; analysis showed no significant difference at the 99% confidence level for any of the preparations when assayed by the microbiological or HPLC method.
A study was initiated to ascertain the suitability of the proposed method for stability studies. Samples of capsule, injection, and granule formulations were stored in temperature-controlled cabinets (ambient or 80 to 150°C). Samples were taken from the cabinets periodically for microbiological and HPLC assays. The assay values, expressed as a percentage of the level claimed, are given in Table 3 . The paired values in Table 3 This study demonstrates the applicability of the proposed HPLC method for the potency determination of amoxicillin in bulk drug and capsule, injection, and granule formulations. The method can be successfully used for routine quality control and stability assays and offers advantages in speed, simplicity, and reliability.
